Related Experiment Video
Updated: Jul 18, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.1K
An Early Detection and Classification of Alzheimer's Disease Framework Based on ResNet-50
V P Nithya1, N Mohanasundaram2, R Santhosh2
1Department of Computer Science and Engineering, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
Current Medical Imaging
|August 25, 2023
Summary
This study introduces an advanced Alzheimer's disease (AD) detection system using a ResNet-50 model and image preprocessing. The method achieves 95% accuracy for reliable early AD diagnosis.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Alzheimer's disease (AD) poses a significant global health challenge.
- Early detection is crucial for effective management and treatment of AD.
- Conventional methods often lack the sensitivity and specificity required for early diagnosis.
Purpose of the Study:
- To develop an effective early detection system for Alzheimer's disease (AD).
- To leverage Deep Residual Network (ResNet) models and advanced image preprocessing techniques for improved AD classification.
- To address limitations of traditional Convolutional Neural Networks (CNNs) in feature extraction for AD detection.
Main Methods:
- Utilized Contrast Limited Adaptive Histogram Equalizer (CLAHE) and Boosted Anisotropic Diffusion Filters (BADF) for image preprocessing (equalization and noise reduction).
- Employed K-means clustering for segmentation of MRI scans.
- Developed a ResNet-50 model with shortcut connections for efficient feature extraction from AD patient MRI data.
Main Results:
- The proposed ResNet-50 based method achieved a high accuracy of 95% with minimal loss (0.12).
- Demonstrated superior performance compared to other models, avoiding overfitting issues.
- The framework proved robust and reliable for Alzheimer's disease categorization.
Conclusions:
- The integrated approach of ResNet-50 and image preprocessing offers an effective early detection system for AD.
- Highlights the potential of deep learning and image processing in creating accurate AD diagnostic tools.
- Represents a promising advancement over existing AD classification methods, paving the way for future research.
Related Concept Videos
Alzheimer's Disease: Overview
518
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
518
Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213

